Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Palliative care is defined by the World Health Organization as “an approach that improves the quality of life of patients and their families facing the problem associated with life-threatening illness, through the prevention and relief of suffering by means of early identification and impeccable assessment and treatment of pain and other problems, physical, psychosocial and spiritual.” The field of palliative medicine was developed over the course of the late 20th century in response to increased awareness of the impact of suffering on quality of life in a context of care previously divided into disease-directed therapy or comfort care. Dame Cicely Saunders, one of the founders of the field, described four broad domains of palliative care: physical, i.e., symptoms; psychological; social; and spiritual. Palliative care can be delivered across a multitude of care contexts and by a variety of providers and should be viewed as distinct from hospice, defined later. Palliative care is also referred to in some contexts as supportive care.
According to some estimates, approximately 75% of patients approaching end of life would benefit from palliative care. Estimates of future needs suggest a 40% increase in these needs by 2040, driven predominantly by dementia and cancer. Illnesses treated by palliative care teams include heart disease, cancer, stroke, diabetes, renal disease, Parkinson’s disease, and Alzheimer’s disease.
One of the focal components of palliative care delivery is the multidisciplinary team model, which is designed to provide comprehensive symptom management and to address psychological, social, and spiritual needs. Although the specific members may vary by institution, a palliative care team often involves the patient and their supporters, a palliative physician, other providers on the patient’s care team, a nurse, social worker, pharmacist, and chaplain as well as volunteers. Physical and occupational therapists and dietitians are also frequently incorporated onto palliative care teams.
Whereas palliative care can be implemented at any stage in care, the term “hospice” specifically describes noncurative, comfort-targeted care delivered to patients nearing the end of life. Patients referred to hospice have a life expectancy of 6 months or less as assessed by two physicians. Many features of hospice care, including a multidisciplinary care team and a focus on comprehensive symptom management, are shared with palliative care; however, patients enrolled on hospice care no longer receive disease-directed therapies targeting their life-limiting illness. Hospice care is traditionally delivered in the home but can also be provided across a variety of other settings, including inpatient units and nursing homes. In the United States, hospice care is funded through a provision in Medicare. A comparison of palliative care and hospice is seen in Table 43.1 .
Palliative care | Hospice |
---|---|
A medical specialty | An insurance benefit |
Appropriate at any time during a serious illness, independent of goals or prognosis | Appropriate when two or more physicians determine likely prognosis of 6 months or less |
Continued curative or life-prolonging therapies available | Goal of comfort-focused care |
Can follow the patient anywhere | Provided at home, in a long-term care facility, or at an inpatient hospice |
Although palliative medicine is a dedicated medical subspecialty, many of the basic domains of palliative care can be delivered by all providers. Primary palliative care has been defined as “the basic [palliative] skills and competencies required of all physicians and other health-care professionals.” In a seminal 2013 paper, Quill and Abernethy describe a series of skill sets that all clinicians should be capable of delivering, including basic management of pain, depression, anxiety, and other symptoms as well as basic discussions about prognosis, goals of treatment, suffering, and code status. Specialist consultation is recommended for guidance regarding management of refractory physical or complex psychological symptoms as well as for assistance with management of conflict among stakeholders and in cases of near-futility ( Table 43.2 ). These recommendations are congruent with consensus statements from the Center to Advance Palliative Care (CAPC), which further recommend that hospitals should develop screening assessments to identify unmet palliative needs in patients.
Primary palliative care | Specialty palliative care |
---|---|
Basic pain and symptom management (including depression and anxiety) | Refractory pain and symptoms; complex depression, anxiety, grief, existential distress |
Routine discussions about:
|
Conflict between families, staff, and medical teams related to goals or treatments |
Delivered by primary provider | Ethical challenges or cases of near futility |
Delivered by specialized, multidisciplinary team |
According to a recent study, some 8% of American adults aged 65 years or older would benefit from primary palliative care for management of advanced chronic illnesses, predominantly chronic obstructive pulmonary disease (COPD) and congestive heart failure (CHF). Palliative-focused organizations such as CAPC, Vitaltalk, and Ariadne Labs have developed tools designed to inform and improve primary palliative care delivery by providing a paradigm for introducing difficult topics and decisions. Two examples of such tools are depicted in Table 43.3 .
Discussing bad news: SPIKES | Addressing goals of care: REMAP |
---|---|
|
|
Advance care planning describes the engagement of patients and their family members around decisions that may need to be made regarding their current and future medical care. This process frequently includes discussion of current and anticipated medical needs with elicitation of the patient’s preferences for utilization of life-sustaining treatments; for example, cardiopulmonary resuscitation, prolonged mechanical ventilation, artificial nutrition and hydration, or comfort care. These preferences may be codified in the form of an advance directive. Palliative care providers may initiate or assist in advance care planning, particularly in complex or conflicted situations.
Patients with life-limiting illnesses frequently experience a combination of symptoms, the nature of which may vary over the course of their illness. Disease-specific symptomatology is addressed later by disease. Table 43.4 describes symptoms and management strategies in detail. Table 43.5 specifically addresses management of cancer pain.
Symptom | Pharmacologic therapies | Nonpharmacologic therapies |
---|---|---|
Anorexia | Megestrol (may increase risk of thrombus in patients in procoagulant states) Corticosteroids Cannabinoids (nabilone and dronabinol) Mirtazapine Olanzapine Melatonin |
Patient/family counseling regarding expectations |
Anxiety | Benzodiazepines, SSRIs, SNRIs, atypical antipsychotics (second line) | Supportive psychotherapy Relaxation Guided imagery Hypnosis Treatment of physical etiology Discontinuation of anxiety-inducing medications (e.g. corticosteroids, baclofen, caffeine, methylphenidate) |
Constipation | Laxatives (emollient stool softeners), bulk-forming agents, osmotic agents, prosecretory drugs, selective opioid-receptor antagonists (e.g., methylnaltrexone, naloxegol) | High-fiber diet, increase fluid intake, discontinue/reduce doses of constipating medications (anticholinergics, opioids) |
Delirium | Typical/ atypical antipsychotics, benzodiazepines (terminal delirium) | Reorientation, optimization of sleep–wake cycle, limitation of environmental stimuli |
Depression | SSRIs SNRIs Stimulants (in end-of-life patients); mirtazapine; trazodone; bupropion |
Supportive psychotherapy, dignity therapy |
Dry mouth | Oral swabs and coating agents, discontinuation of triggering agents (antihistamines, anticholinergics) | |
Dyspnea | Opioids (decrease respiratory drive) Benzodiazepines (reduce anxiety) Diuretics (HF) Bronchodilator therapy (COPD) Corticosteroids (COPD) |
Supplemental oxygen (evidence is mixed) Fan Cognitive therapy |
Fatigue | Methylphenidate Steroids (for end-stage/hospice patients only) |
Encourage exercise/activity |
Nausea | 5HT-3 receptor antagonists, antimuscarinics, antidopaminergics, neurokinin-1 receptor antagonists, cannabinoids, corticosteroids, benzodiazepines | Gastric decompression, discontinuation/rotation of nausea-inducing medications (opioids) |
Pain | Opioids, NSAIDs, neuropathic agents (see Table 43.5 for more detail) |
Disease-directed therapies (chemotherapy/radiation/surgery/diuresis), physical therapy, complementary therapies (e.g., music therapy, massage) |
Pruritis | Antihistamines, opioid antagonists (nalbuphine, naloxone) | Treatment of uremia (dialysis) Discontinuation of stimulating agents/opioid rotation |
Pain type | Etiology | Description | Example | Therapeutic options |
---|---|---|---|---|
Visceral | Distension/displacement/inflammation of solid and hollow organs | Diffuse, cramping, difficult to localize, may be referred | Abdominal pain from intraabdominal malignancy causing partial/complete bowel obstruction | Opioids, corticosteroids in some cases, treatment of etiology |
Somatic | Compression/injury of muscular, bony and integumentary tissues | Aching, dull, easily localized | Back pain caused by spinal metastases | Opioids, NSAIDs/anti-inflammatory agents (including corticosteroids) |
Neuropathic | Injury of nerve tissues (related to compression/infiltration by tumor; often treatment-induced) | Radiating, burning, may be associated with paresthesia | Radiating/ burning upper extremity pain in setting of tumor infiltration of brachial plexus | Neuropathic agents (gabapentinoids, SSRIs, SNRIs, tricyclic antidepressants), opioids (especially methadone), ketamine |
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here